EP1667681A4 - Nouveau systeme d'administration transmucosale - Google Patents

Nouveau systeme d'administration transmucosale

Info

Publication number
EP1667681A4
EP1667681A4 EP04745093A EP04745093A EP1667681A4 EP 1667681 A4 EP1667681 A4 EP 1667681A4 EP 04745093 A EP04745093 A EP 04745093A EP 04745093 A EP04745093 A EP 04745093A EP 1667681 A4 EP1667681 A4 EP 1667681A4
Authority
EP
European Patent Office
Prior art keywords
delivery system
transmucosal delivery
novel
novel transmucosal
transmucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04745093A
Other languages
German (de)
English (en)
Other versions
EP1667681A1 (fr
Inventor
Jayanta Kumar Mandal
Shashank Bababhai Patel
Kirti Bansidhar Maheshwari
Padma Venkitachalam Devarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astron Research Ltd
Original Assignee
Astron Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astron Research Ltd filed Critical Astron Research Ltd
Publication of EP1667681A1 publication Critical patent/EP1667681A1/fr
Publication of EP1667681A4 publication Critical patent/EP1667681A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP04745093A 2003-10-03 2004-01-20 Nouveau systeme d'administration transmucosale Withdrawn EP1667681A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1027MU2003 2003-10-03
PCT/IN2004/000013 WO2005032554A1 (fr) 2003-10-03 2004-01-20 Nouveau systeme d'administration transmucosale

Publications (2)

Publication Number Publication Date
EP1667681A1 EP1667681A1 (fr) 2006-06-14
EP1667681A4 true EP1667681A4 (fr) 2009-09-30

Family

ID=34401273

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04745093A Withdrawn EP1667681A4 (fr) 2003-10-03 2004-01-20 Nouveau systeme d'administration transmucosale

Country Status (2)

Country Link
EP (1) EP1667681A4 (fr)
WO (1) WO2005032554A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1973952A4 (fr) 2006-01-23 2010-09-01 Kwangju Inst Sci & Tech Conjugué comprenant un composé pharmaceutiquement actif lié de façon covalente à un polymère mucoadhésif et méthode d'administration transmucosale de composé pharmaceutiquement actif faisant appel audit conjugué
AR056062A1 (es) 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
CA2665226C (fr) * 2006-10-05 2014-05-13 Santarus, Inc. Nouvelles formulations pour une liberation immediate d'inhibiteurs de pompe a protons et procedes d'utilisation de ces formulations
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
IT201700124424A1 (it) 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali
IT201700124434A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0567201A2 (fr) * 1986-04-30 1993-10-27 Aktiebolaget Hässle Véhicules pour l'administration orale de substances pharmaceutiques sensibles aux acides
WO1997012580A2 (fr) * 1995-09-21 1997-04-10 Pharma Pass Llc Nouvelle composition contenant un benzimidazole labile a l'acide et procede de preparation
WO1998052564A1 (fr) * 1997-05-23 1998-11-26 Cipla Limited Composition pharmaceutique contenant du benzimidazole et procede de preparation
WO1999029320A1 (fr) * 1997-12-08 1999-06-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelle forme galenique comprenant un compose actif acido-labile
US6294586B1 (en) * 1998-05-05 2001-09-25 Sepracor Inc. Hydroxyomeprazole compositions and methods
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885565A (en) 1993-03-19 1999-03-23 Cellegy Pharmaceuticals Inc. Methods for inducing phase separation of epithelial lipid bilayers
PT869772E (pt) 1995-12-27 2002-03-28 Janssen Pharmaceutica Nv Forma galenica solida bioadesiva
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
JP4065642B2 (ja) 2000-02-24 2008-03-26 扶桑薬品工業株式会社 消化器系疾患の予防、治療用組成物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0567201A2 (fr) * 1986-04-30 1993-10-27 Aktiebolaget Hässle Véhicules pour l'administration orale de substances pharmaceutiques sensibles aux acides
WO1997012580A2 (fr) * 1995-09-21 1997-04-10 Pharma Pass Llc Nouvelle composition contenant un benzimidazole labile a l'acide et procede de preparation
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
WO1998052564A1 (fr) * 1997-05-23 1998-11-26 Cipla Limited Composition pharmaceutique contenant du benzimidazole et procede de preparation
WO1999029320A1 (fr) * 1997-12-08 1999-06-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelle forme galenique comprenant un compose actif acido-labile
US6294586B1 (en) * 1998-05-05 2001-09-25 Sepracor Inc. Hydroxyomeprazole compositions and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005032554A1 *

Also Published As

Publication number Publication date
WO2005032554A1 (fr) 2005-04-14
EP1667681A1 (fr) 2006-06-14

Similar Documents

Publication Publication Date Title
GB2421914B (en) Delivery devices
GB2405350B (en) Delivery devices
GB0224442D0 (en) A delivery system
GB0218126D0 (en) Drug delivery system
GB0400024D0 (en) Delivery devices
AU155406S (en) Dispenser
PL372172A1 (en) Osmotic delivery system
AU2003228995A8 (en) Content delivery system
GB0307999D0 (en) A system
GB0330163D0 (en) Locker-bank delivery process
GB2389738B (en) Mail delivery system
EP1624822A4 (fr) Nouveaux systemes de distribution de gomme
GB2385637B (en) A package delivery system
GB0302276D0 (en) Mail delivery system
EP1732555A4 (fr) Systeme d'administration d'un opioide
GB0315914D0 (en) A system
GB0327409D0 (en) Delivery system
AU2003905867A0 (en) A Delivery System
GB0321533D0 (en) A lottery system
GB2428706B (en) A supporting system
GB2405649B (en) A supporting system
GB0307020D0 (en) Advanced parcel delivery system
GB0300079D0 (en) A system
GB0327692D0 (en) A system
GB0321914D0 (en) Conveying system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090828

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/16 20060101ALI20090824BHEP

Ipc: A61K 31/4439 20060101ALI20090824BHEP

Ipc: A61K 9/20 20060101AFI20090824BHEP

17Q First examination report despatched

Effective date: 20091126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110802